1. Home
  2. SNOA vs NBY Comparison

SNOA vs NBY Comparison

Compare SNOA & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • NBY
  • Stock Information
  • Founded
  • SNOA 1999
  • NBY 2000
  • Country
  • SNOA United States
  • NBY United States
  • Employees
  • SNOA N/A
  • NBY N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • SNOA Health Care
  • NBY
  • Exchange
  • SNOA Nasdaq
  • NBY Nasdaq
  • Market Cap
  • SNOA 6.9M
  • NBY 6.3M
  • IPO Year
  • SNOA 2007
  • NBY 2007
  • Fundamental
  • Price
  • SNOA $4.00
  • NBY $1.20
  • Analyst Decision
  • SNOA
  • NBY Strong Buy
  • Analyst Count
  • SNOA 0
  • NBY 1
  • Target Price
  • SNOA N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • SNOA 76.8K
  • NBY 466.6K
  • Earning Date
  • SNOA 11-07-2025
  • NBY 11-10-2025
  • Dividend Yield
  • SNOA N/A
  • NBY N/A
  • EPS Growth
  • SNOA N/A
  • NBY N/A
  • EPS
  • SNOA N/A
  • NBY 0.41
  • Revenue
  • SNOA $14,912,000.00
  • NBY $9,781,000.00
  • Revenue This Year
  • SNOA $23.00
  • NBY $23.91
  • Revenue Next Year
  • SNOA $24.59
  • NBY $32.05
  • P/E Ratio
  • SNOA N/A
  • NBY $3.11
  • Revenue Growth
  • SNOA 17.43
  • NBY 113.47
  • 52 Week Low
  • SNOA $1.75
  • NBY $0.46
  • 52 Week High
  • SNOA $6.92
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 49.74
  • NBY 45.80
  • Support Level
  • SNOA $3.57
  • NBY $1.17
  • Resistance Level
  • SNOA $4.02
  • NBY $1.31
  • Average True Range (ATR)
  • SNOA 0.23
  • NBY 0.15
  • MACD
  • SNOA 0.00
  • NBY 0.02
  • Stochastic Oscillator
  • SNOA 58.63
  • NBY 49.43

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: